Central neurotransmitter disturbances underlying developmental neurotoxicological effects.
Transmission of information among neurons is of a chemical nature. The activity of the neurotransmitter in the brain is regulated by the spontaneous activity of neurotransmitter cell body and the sensitivity of both pre- and post-synaptic receptors. Neurotransmitters are present at very early stages of brain development; they do not only mediate the behavioral-physiological responses of the immature animal, but have trophic effects on the maturation of target neurons as well. Many centrally acting drugs which are frequently used also during pregnancy for the treatment of depression, hypertension, epilepsy, asthma, insomnia, hyperkinetism and other neurological and psychiatric disorders act directly on brain neurotransmitters (in particular monoamines) and behavioral states. Chronic administration of drugs acting on monoamines (such as clonidine, imipramine, alpha-methyl-Dopa, reserpine, monoamine oxidase inhibitors, diazepam) disturb the spontaneous activity and behavioral state dependency of the monoaminergic cells, influences neurotransmitter turnover and change the sensitivity of both pre- and post-synaptic receptors. Sensory deprivation during a critical period of development is known to produce permanent effect on the brain; e.g., monocular deprivation during a particular period of development in a kitten leads to a rewiring of the connectivity in the visual system in the adult cat. Disturbances in neurotransmitter activity during early life will induce a comparable reorganization of the chemical structure of the adult brain.
D000818:Animals; D001921:Brain / Q000254:growth & development; D003000:Clonidine / Q000009:adverse effects / Q000633:toxicity; D004347:Drug Interactions; D005260:Female; D006128:Growth / Q000187:drug effects*; D006801:Humans; D009498:Neurotoxins / Q000009:adverse effects / Q000633:toxicity; D018377:Neurotransmitter Agents / Q000502:physiology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D012683:Sensory Deprivation; D009435:Synaptic Transmission / Q000187:drug effects*
D009498:Neurotoxins; D018377:Neurotransmitter Agents; D003000:Clonidine